Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Operating Margin
Qingdao Baheal Medical Inc

12.9%
Current
10%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.9%
=
Operating Profit
973m
/
Revenue
7.5B

Operating Margin Across Competitors

Country CN
Market Cap 14.3B CNY
Operating Margin
13%
Country US
Market Cap 77.7B USD
Operating Margin
1%
Country US
Market Cap 48.6B USD
Operating Margin
1%
Country US
Market Cap 48.4B USD
Operating Margin
1%
Country US
Market Cap 30.3B USD
Operating Margin
1%
Country US
Market Cap 9.3B USD
Operating Margin
5%
Country CN
Market Cap 65.2B CNY
Operating Margin
10%
Country KR
Market Cap 12.2T KRW
Operating Margin
9%
Country CN
Market Cap 64.3B HKD
Operating Margin
4%
Country CN
Market Cap 60.5B CNY
Operating Margin
3%
Country IT
Market Cap 5.5B EUR
Operating Margin
12%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
12.9%
=
Operating Profit
973m
/
Revenue
7.5B
What is the Operating Margin of Qingdao Baheal Medical Inc?

Based on Qingdao Baheal Medical Inc's most recent financial statements, the company has Operating Margin of 12.9%.